Bailing Capsule combined with α-ketoacid tablets for stage 3 chronic kidney disease: Protocol of a double-blinded, randomized, controlled trial

BACKGROUND: Chronic kidney disease (CKD) is a progressive and irreversible loss of kidney function. After stage 3, there will be increased risks of hypertension, heart failure, bone disease, anemia, gastrointestinal symptoms, and progression to end-stage kidney failure without proper intervention an...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xiuhong, Wang, Jing, Yang, Hongjuan, Ji, Suhua, Li, Yuhong, Xu, Baozhen, Cui, Hongrui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136994/
https://www.ncbi.nlm.nih.gov/pubmed/34011035
http://dx.doi.org/10.1097/MD.0000000000025759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136994/
https://www.ncbi.nlm.nih.gov/pubmed/34011035
http://dx.doi.org/10.1097/MD.0000000000025759

Ejemplares similares